Hypertrophic Cardiomyopathy Treatment in Turkey
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Hypertrophic Cardiomyopathy?
Hypertrophic cardiomyopathy is a heart muscle disease characterised by abnormal thickening of the ventricular walls. In some patients, the thickened muscle obstructs blood flow; in others, the disease is non-obstructive. HCM can be inherited and may occur at different ages.
What is the Importance of Timely Treatment?
Timely treatment of Hypertrophic Cardiomyopathy helps control symptoms, assess whether thickened heart muscle is obstructing blood flow, reduce the risk of complications such as heart failure and arrhythmias, and identify patients who may benefit from an implantable cardioverter-defibrillator (ICD). Regular follow-up also supports long-term heart health by guiding medicines, activity, lifestyle, and family screening.
What are the Common Symptoms of Hypertrophic Cardiomyopathy?
- Shortness of Breath: Breathlessness may occur during physical activity or, in more advanced cases, at rest.
- Chest Pain: Some patients experience chest discomfort, particularly during exertion.
- Palpitations: A sensation of a racing, pounding, or irregular heartbeat may occur because of abnormal heart rhythms.
- Dizziness: Reduced cardiac output or abnormal rhythms may cause lightheadedness, particularly during activity.
- Fainting: Episodes of unexplained fainting may occur and require medical evaluation, especially in people with known HCM.
- Fatigue: Reduced ability of the heart to fill or pump efficiently can lead to tiredness and reduced exercise tolerance.
Causes and Risk Factors of Hypertrophic Cardiomyopathy
Causes
- Inherited Genetic Changes: Most familial HCM is linked to genetic variants that affect proteins involved in heart muscle contraction.
- Spontaneous Genetic Changes: Some patients develop HCM without a known family history.
- Unexplained Causes: In some individuals, no specific genetic or other cause is identified.
- Associated Conditions: Some heart-muscle disorders can produce thickening that resembles HCM and require careful evaluation to distinguish them from true HCM.
Risk Factors
- Family History: Having a first-degree relative with HCM or unexplained sudden cardiac death can increase risk.
- Genetic Predisposition: Inherited disease-causing variants can increase susceptibility.
- Age: HCM can become apparent during childhood, adolescence, adulthood, or later life.
- Previous Abnormal Cardiac Findings: Unexplained heart-muscle thickening or abnormal ECG findings may prompt further assessment.
- Family History of Sudden Cardiac Death: This may be an important factor in individual risk assessment.
Latest Research and Technologies in the Treatment of Hypertrophic Cardiomyopathy in Turkey
- Recent advances in HCM care include cardiac MRI for detailed assessment of heart muscle thickness and scar tissue, advanced echocardiography for evaluating blood-flow obstruction, and genetic testing for selected patients and families. Newer cardiac myosin inhibitors, provide a targeted treatment option for selected adults with symptomatic obstructive HCM. Advanced risk assessment also helps identify patients who may benefit from ICDs, while specialised centres can offer septal reduction procedures, including surgical myectomy and selected catheter-based approaches.
Treatment options for Hypertrophic Cardiomyopathy
Septal Myectomy: This open-heart surgical procedure (Morrow procedure) remains the gold-standard intervention to physically excise a portion of the hypertrophied septum and relieve left ventricular outflow tract (LVOT) obstruction.
Alcohol Septal Ablation: A minimally invasive, catheter-based alternative to surgery where pure alcohol is injected into a septal branch artery to induce a localised controlled infarction, thinning the muscle to reduce obstruction.
Implantable Cardioverter-Defibrillator (ICD) : some HCM patients have an increased risk of sudden cardiac death, and ICD decisions are based on individual risk assessment.
Cost Start From 20000Explore Options
Heart Transplantation : For the small percentage of HCM patients who progress to end-stage, non-obstructive "burnt-out" heart failure, an orthotopic heart transplant is the final definitive option
- Clinical assessment:
- Medical and Family History: Assessment of symptoms, exercise tolerance, previous fainting, family history of HCM, and sudden cardiac death.
- Physical Examination: Evaluation for heart murmurs, abnormal heart sounds, blood pressure changes, and signs of heart failure.
- Electrocardiogram (ECG): May identify abnormal electrical patterns associated with HCM.
- Holter or Ambulatory ECG Monitoring: Detects intermittent arrhythmias that may not appear on a standard ECG.
- Exercise Testing: May assess exercise capacity, blood pressure response, symptoms, and exercise-related obstruction.
- Genetic Testing: May be offered to selected patients to identify disease-causing variants and support family screening.
- Imaging Tests:
- Echocardiography: The main imaging test used to assess heart-muscle thickness, heart function, valve movement, and obstruction.
- Cardiac MRI: Provides detailed images of heart structure and can identify myocardial scar and other tissue characteristics.
- Stress Echocardiography: May reveal obstruction or abnormalities that become apparent during exercise.
- Chest X-ray: May help evaluate heart size and associated lung findings when clinically indicated.
- Cardiac CT: Consider in selected patients when additional anatomical information is needed.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support hypertrophic cardiomyopathy patients in Turkey. These services include:
- Individualised Exercise: Specialists can recommend appropriate physical activity based on symptoms, disease severity, and individual needs.
- Cardiac Rehabilitation: Selected patients may benefit from structured, supervised rehabilitation.
- Physical Conditioning: Gradual activity can help maintain functional capacity while avoiding inappropriate exertion.
- Weight Management: Maintaining a healthy weight can reduce additional cardiovascular strain.
- Long-Term Follow-Up: Regular cardiology assessments help monitor symptoms, heart function, rhythm, and response to treatment.
- Select medicines based on symptoms, obstruction, heart rhythm, and overall heart function. Beta-blockers and certain calcium-channel blockers may help reduce symptoms and improve ventricular filling. Selected patients with obstructive HCM may receive cardiac myosin inhibitors, while antiarrhythmic or anticoagulant medicines may be prescribed when clinically indicated. Treatment should be supervised by a cardiologist experienced in HCM.
Instantly Connect with our Specialists
Hospitals for Hypertrophic Cardiomyopathy in Turkey
Antalya Anadolu Hastanesi
Antalya, Turkey
Apart from in-detail treatment procedures available, Antalya Anadolu Hastanesi located in Antalya , Turkey has a wide variety of facilities available for International Patients. Some of the facilities which are provided by them are Accommodation, Airport Transfer, Choice of Meals, Interpreter, TV inside room. Also listed below are some of the most prominent infrastructural details:
- A technological powerhouse, it provides 24*7 trauma care.
- 4 suites and 54 luxurious rooms
- 3 exceptional operating theatres
- 3 Intensive Care Units
- Efficient and capable healthcare personnel
- Focus on patient care, reasonable prices
- State of the art diagnostics setup
- Recognised for providing integrated care for complex cases and rare cases
- Latest 1.5 Tesla MR, 64 2 Multi-slice Computed Tomography (CT), coronary angiography, and panendoscope
- Treatments such as angioplasty(PTCA), cryotherapy, IVF, ERCP, peritoneoscopy, facial palsies, and electro shock wave lithotripsy are available
- Widely experienced and well educated healthcare professionals are at the forefront of healthcare delivery at the Antalya Anadolu Hospital, Antalya, Turkey
Medipol Mega University Hospital
Istanbul, Turkey
Medipol Mega University Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- The Hospital includes 4 centers i.e. general surgery, cardiovascular surgery, oncology, and dentistry
- Medipol patients have access to over 60,000 m2 of the gardens, 26,000 m2 of the five-storied underground parking, 100,000 m2 covered premises and 1,500 members of the stuff
- Capacity of 470 patient beds
- Oncology Center
- Emergency department that can admit up to 134 patients (including general, coronary, KVC and neonatal emergency department)
- 25 Operating rooms
- Medipol Mega University Hospital uses the following innovative technologies- Biplane digital flat-panel angiographic system, Digital flat-panel tomosynthetic mammography, Surgical O-ARM PEROP CT Imaging system, etc.
- Helicopters enabling the transfer of the patient at the most emergency cases
- The Hospital creates a friendly & comfortable ambience for the patients and their relatives with terrace garden suites, normal rooms. Each room is equipped with multimedia services like TV, DVD, Internet, online access from patients bedside, Unlimited Digital Archive pacs and high-quality meal service
- Prayer Room
- 5-starred cafeteria/restaurant
Medstar Antalya Hospital
Ankara, Turkey
- Medstar Antalya Hospital has been providing patients with modern medical services since 2009.
- It is part of the trusted Memorial Health Group, which is known for expert healthcare in Turkey.
- The hospital is situated on a large campus and features advanced medical equipment and facilities.
- It has 124 comfortable beds for patients and five fully prepared operating rooms for surgeries.
- There are 33 intensive care beds, including specialised units for newborns who require additional support.
- The hospital treats many health issues like cancer, heart problems, brain conditions, and more.
- Modern machines, such as MRI, CT, and PET-CT, help doctors identify and treat problems quickly and safely.
- Medstar meets international safety and care standards and is trusted by both local and global patients.
- Care plans are made specially for each person, and emotional well-being is also supported.
- Its location in Antalya makes it easy to reach and ideal for people coming from other countries for treatment.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Turkey for Hypertrophic Cardiomyopathy Treatment?
- Experienced Cardiac Specialists: Turkey has cardiologists, electrophysiologists, cardiac surgeons, and specialists experienced in managing complex heart-muscle disorders.
- Advanced Cardiac Imaging: Major centres may offer advanced echocardiography, cardiac MRI, CT, and ambulatory rhythm monitoring.
- Specialised HCM Management: Appropriate patients may have access to medicines, cardiac myosin inhibitors, septal myectomy, alcohol septal ablation, and ICD implantation.
- Advanced Electrophysiology Services: Specialist centres can evaluate and manage arrhythmias and assess the need for ICDs.
- Multidisciplinary Care: Cardiology, electrophysiology, cardiac surgery, genetics, imaging, rehabilitation, and other specialists can collaborate for complex cases.
- Genetic Evaluation: Selected patients and families can undergo genetic counselling and testing where appropriate.
- Personalised Treatment: Management is tailored according to symptoms, obstruction, heart function, arrhythmia risk, and genetic or family history.
- International Patient Support: Many major Turkey hospitals offer assistance with appointments, treatment coordination, accommodation, and follow-up for international patients.
Frequently Asked Questions
Reviewer
Dr. Nityanand Tripathi
Interventional Cardiologist
29 Years of Experience
With a rich experience of more than 29 years, Dr. Nityanand has gained a vast spectrum of skills and expertise in performing all types of complex cardiac procedures. He is an expert in clinical & interventional cardiology and electrophysiology. He studied his medicine (MBBS) and MD from the Institute of Medical Sciences of Banaras Hindu University, Varanasi, and later completed his DM in Cardiology from the prestigious King George Medical University, Lucknow. View More
Last Reviewed - January 2026